Skip to the page

Data / Medical devices / United States / Instylla, Inc.

Instylla, Inc.: FDA-registered device maker in Bedford, MA, United States, 5 510(k) clearances and 1 PMA approval

Instylla, Inc. is registered with the FDA (registration 3017208642) in Bedford, MA, United States. It lists 3 device types. The FDA files 5 510(k) clearances and 1 PMA approval under its listings, the newest dated December 22, 2025. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3017208642
Address
201 Burlington Rd, North Building, Bedford, MA, United States, 01730
Owner or operator
Instylla, Inc. (10077890)
Roles
Manufacturer
First device listed
October 5, 2020
Registered through
2026
Brand names listed
Embrace Hydrogel Embolic System, Instylla Delivery Kit, Instylla Delivery Kit 1mL:1mL, Instylla Microcatheter, Instylla Microcatheter 1.2F

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
December 22, 2025K253769Instylla Delivery KitFMFSubstantially EquivalentInstylla, Inc.accessdata.fda.gov
February 10, 2022K213632Instylla Delivery KitFMFSubstantially EquivalentInstylla, Inc.accessdata.fda.gov
April 15, 2021K210808Instylla Microcatheter 1.2KRASubstantially EquivalentInstylla, Inc.accessdata.fda.gov
April 21, 2020K200744Instylla MicrocatheterKRASubstantially EquivalentInstylla, Inc.accessdata.fda.gov
October 10, 2019K191659Instylla Delivery KitFMFSubstantially EquivalentInstylla, Inc.accessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
August 5, 2025P250003Embrace(TM) Hydrogel Embolic SystemQVG10October 23, 2026accessdata.fda.gov

Compare with other makers

Updated October 23, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.